Last reviewed · How we verify

NCT05376163

Validity of Headache Disability Index

Status unknown Last updated 4 August 2022
What this trial tests

trial testing Survey Study in Neck Pain in 250 participants. Status unknown.

Timeline
1 September 2022
Primary endpoint
1 October 2022
1 November 2022

Quick facts

Lead sponsorHacettepe University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment250
Start date1 September 2022
Primary completion1 October 2022
Estimated completion1 November 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 18 to 65, any sex, with Neck Pain or Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of our study is to investigate the Turkish validity and reliability of The Henry Ford Hospital Headache Disability Questionnaire (HDI), which has not been previously studied in a Turkish version for any headache type in patients with cervicogenic headache.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Survey Study

Trials testing the same drug.

Other recruiting trials for Neck Pain

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05376163.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing